Blog

To view blog posts prior to July 2010, click here.

The Memphis Business Group on Health (MBGH) is pleased to make this forum, including all web pages and web sites accessed from this page, available to Web Site users and others. However, the MBGH does not render legal or consultation services, and legal counsel must be consulted to determine any material’s applicability to any specific situation. MBGH cannot warrant or control the quality, accuracy, or validity of the information posted here. Comments posted on this blog are the sole responsibility of their writers. Use of such information is at the risk of the accessing user and the accessing user assumes all liabilities that may result from such use.


MBGH Joins the National Alliance in a New Vision for Specialty Drugs Marketplace

To drive collaboration to control cost, reduce waste and maximize effectiveness of specialty drugs, the non-profit National Alliance of Healthcare Purchaser Coalitions (National Alliance) has developed stakeholder guidelines and an engagement framework.

“Specialty drugs are the fastest growing area of spend for employers today,” said Mike Thompson, National Alliance president and CEO. “While these new drugs are truly innovative and important, the specialty drug marketplace itself is dysfunctional with high cost, high variation and high waste. We need to collaborate with stakeholders to wring out the costs of poor quality and unwarranted cost, complexity and conflicts.”

The Five Rights framework targets critical issues and opportunities for specialty stakeholders including manufacturers, providers, health plans, and pharmacy benefit managers. The framework outlines key areas for each stakeholder to improve and was developed to raise purchaser expectations for industry stakeholders to help them better understand, evaluate and improve the specialty drug marketplace.

The Five Rights are: Right Drug, Right Price, Right Place, Right Support and Right Data. Employers should use the stakeholder engagement framework to evaluate how specialty drugs are managed by their PBM and health administrator and work with their vendors to take actions to bring their programs into alignment. 

The framework was developed as a collaborative effort of the National Alliance and several purchaser-led member coalitions including the Minnesota Health Action Group, Midwest Business Group on Health and the Florida Health Care Coalition. The information is being shared with purchaser coalitions across the country.

“After two years of intensive study, Action Group members developed this framework to offer a common ground for all stakeholders,” said Carolyn Pare, president and CEO for the Minnesota Health Action Group, developer of the initial Five Rights. “Offering a road map for the Right Drug, Right Price, Right Place, Right Support and Right Data, this framework provides insights for each stakeholder to do their part to deliver on that promise.”

Posted by Cristie Travis at 6:54 AM

Comments

No Comments yet!

Leave A Comment

Please answer the simple math question below to submit the form.
1 + 2 =

Say Hello

Please feel free to drop us a line via the button below. We try to respond to every email we receive.

Stay Connected

Join the MBGH community and keep up to date with issues concerning Memphis healthcare.

Facebook Twitter LinkedIn Feed